NCT01609010 2014-09-08A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) LymphomaHoffmann-La RochePhase 3 Completed313 enrolled 15 charts